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We consider multivariate two-sample tests of means, where the
location shift between the two populations is expected to be related
to a known graph structure. An important application of such tests
is the detection of differentially expressed genes between two patient
populations, as shifts in expression levels are expected to be coherent
with the structure of graphs reflecting gene properties such as biologi-
cal process, molecular function, regulation or metabolism. For a fixed
graph of interest, we demonstrate that accounting for graph struc-
ture can yield more powerful tests under the assumption of smooth
distribution shift on the graph. We also investigate the identification
of nonhomogeneous subgraphs of a given large graph, which poses
both computational and multiple hypothesis testing problems. The
relevance and benefits of the proposed approach are illustrated on
synthetic data and on breast and bladder cancer gene expression
data analyzed in the context of KEGG and NCI pathways.
1. Introduction. The detection of differentially expressed (DE) genes,
that is, genes whose expression levels change between two (or more) ex-
perimental conditions, remains a major challenge in biology and medicine,
especially in the context of cancer studies. For example, the identification
of DE genes between breast cancer patients that are sensitive or resistant
to tamoxifen can help understand resistance mechanisms to this drug and
eventually improve breast tumor treatment [Loi et al. (2008)]. Similarly,
finding DE genes between low-grade, noninvasive or more aggressive blad-
der tumors may help understand the disease better and ultimately improve
its diagnosis and treatment [Stransky et al. (2006)]. The application of the
methods developed in this paper will be illustrated on the data sets from
the above two papers.
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However, the detection of a change in gene expression levels among a large
gene list is a difficult problem from a statistical perspective, and lists of
differentially expressed genes are generally hard to interpret, as they fo-
cus on the level of genes instead of the level of molecular functions. In
such a context, expression data from high-throughput microarray and se-
quencing assays gain much in relevance from their association with graph-
structured prior information on the genes, for example, Gene Ontology
(GO; http://www.geneontology.org), Kyoto Encyclopedia of Genes and
Genomes (KEGG; http://www.genome.jp/kegg) or NCI Pathway Integra-
tion Database (NCI graphs; http://pid.nci.nih.gov). Most approaches
to the joint analysis of gene expression data and gene graph data involve two
distinct steps. First, tests of differential expression are performed separately
for each gene. Then, these univariate (gene-level) testing results are extended
to the level of gene sets, for example, by assessing the over-representation
of DE genes in each set based on p-values for Fisher’s exact test1 (or a χ2
approximation thereof) adjusted for multiple testing [Beissbarth and Speed
(2004)] or based on permutation adjusted p-values for weighted Kolmogorov–
Smirnov-like statistics [Subramanian et al. (2005)]. Another family of meth-
ods directly performs multivariate tests of differential expression for groups
of genes, for example, Hotelling’s T 2-test [Lu et al. (2005)]. It is known
[Goeman and Bu¨hlmann (2007)] that the former family of approaches can
lead to incorrect interpretations, as the sampling units for the tests in the
second step become the genes (as opposed to the patients) and these are ex-
pected to have strongly correlated expression measures. This fact suggests
that direct multivariate testing of gene set differential expression is more ap-
propriate than posterior aggregation of individual gene-level tests. On the
other hand, while Hotelling’s T 2-statistic is known to perform well in small
dimensions, it loses power very quickly with increasing dimension [Bai and
Saranadasa (1996)], essentially because it is based on the inverse of the em-
pirical covariance matrix which becomes ill-conditioned. Additionally, such
direct multivariate tests on unstructured gene sets do not take advantage of
information on gene regulation or other relevant biological properties. An
increasing number of regulation networks are becoming available, specifying,
for example, which genes activate or inhibit the expression of which other
genes. If it is known that a particular gene in a tested gene set activates
the expression of another, then one expects the two genes to have coherent
(differential) expression patterns, for example, higher expression of the first
gene in resistant patients should be accompanied by higher expression of the
second gene in these patients. Accordingly, the first main contribution of this
paper is to propose and validate multivariate test statistics for identifying
differential expression patterns (or, more generally, shifts in distribution)
that are coherent with a given graph structure.
1Sometimes referred to as a hypergeometric test in the bioinformatics literature.
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Next, given a large graph and observations from two data generating
distributions on the graph, a more general problem is the identification of
smaller nonhomogeneous subgraphs, that is, subgraphs on which the two
distributions (restricted to these subgraphs) are significantly different. This
is very relevant in the context of tests for gene set differential expression:
given a large set of genes, together with their known regulation network, or
the concatenation of several such overlapping sets, it is important to discover
novel gene sets whose expression changes significantly between two condi-
tions. Currently-available gene sets have often been defined in terms of other
phenomena than that under study and physicians may be interested in dis-
covering sets of genes affecting in a concerted manner a specific phenotype.
Our second main contribution is therefore to develop algorithms that allow
the exhaustive testing of all the subgraphs of a large graph, while avoiding
one-by-one enumeration and testing of these subgraphs and accounting for
the multiplicity issue arising from the vast number of subgraphs.
As the problem of identifying variables or groups of variables which dif-
fer in distribution between two populations is closely related to supervised
learning, our proposed approach is similar to several learning methods. Ra-
paport et al. (2007) use filtering in the Fourier space of a graph to train
linear classifiers of gene expression profiles whose weights are smooth on
a gene network. However, their classifier enforces global smoothness on the
large regularization network of all the genes, whereas we are concerned with
the selection of gene sets with locally-smooth expression shift between pop-
ulations. In Jacob, Obozinski and Vert (2009) and Obozinski, Jacob and
Vert (2011), sparse learning methods are used to build a classifier based on
a small number of gene sets. While this approach leads in practice to the
selection of groups of variables whose distributions differ between the two
classes, the objective is to achieve the best classification performance with
the smallest possible number of groups. As a result, correlated groups of
variables are typically not selected. Other related work includes Fan and
Lin (1998), who proposed an adaptive Neyman test in the Fourier space for
time series. However, as illustrated below in Section 5, direct translation of
the adaptive Neyman statistic to the graph case is problematic, as assump-
tions on Fourier coefficients which are true for time series do not hold for
graphs. In addition, the Neyman statistic converges very slowly toward its
asymptotic distribution and the required calibration by bootstrapping ren-
ders its application to our subgraph discovery context difficult. By contrast,
other methods do not account for shift smoothness and try to address the
loss of power caused by the poor conditioning of the T 2-statistic by applying
it after dimensionality reduction [Ma and Kosorok (2009)] or by omitting
the inverse covariance matrix and adjusting instead by its trace [Bai and
Saranadasa (1996), Chen and Qin (2010)] or using a diagonal estimator of
the covariance matrix [Srivastava and Du (2008), Srivastava (2009)]. Lopes,
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Jacob and Wainwright (2011) recently proposed a testing procedure based
on random projection of the data in a lower dimension space, and showed
that it was asymptotically more powerful than Bai and Saranadasa (1996),
Chen and Qin (2010) and Srivastava and Du (2008) in the presence of corre-
lation and when the spectrum of the covariance matrix decays fast enough.
Vaske et al. (2010) recently proposed DE tests, where a probabilistic graph-
ical model is built from a gene network. However, this model is used for
gene-level DE tests, which then have to be combined to test at the level of
gene sets. Several approaches for subgraph discovery, like that of Ideker et al.
(2002), are based on a heuristic to identify the most differentially expressed
subgraphs and do not amount to testing exactly all possible subgraphs.
Concerning the discovery of distribution-shifted subgraphs, Vandin, Upfal
and Raphael (2010) propose a graph Laplacian-based testing procedure to
identify groups of interacting proteins whose genes contain a large number
of mutations. Their approach does not enforce any smoothness on the de-
tected patterns (smoothness is not necessarily expected in this context) and
the graph Laplacian is only used to ensure that very connected genes do not
lead to spurious detection. The Gene Expression Network Analysis (GXNA)
method of Nacu et al. (2007) detects differentially expressed subgraphs based
on a greedy search algorithm and gene set DE scoring functions that do not
account for the graph structure.
The rest of this paper is organized as follows. Section 2 explains how
to build a lower-dimension basis in which to apply the multivariate test of
means. Section 3 presents our graph-structured two-sample test statistic and
states results on power gain for smooth-shift alternatives. Section 4 describes
procedures for systematically testing (without fully enumerating) all possible
subgraphs of a large graph. Section 5 presents results for synthetic data and
Section 6 on breast and bladder cancer gene expression data sets analyzed
in the light of pathways from the KEGG and NCI databases. Section 7
presents softwares implementing the proposed methods. Finally, Section 8
summarizes our findings and outlines ongoing work.
Although this work is motivated by the specific question of differential
expression testing of gene networks, our proposed structured two-sample test
of means on a graph and our nonhomogeneous subgraph discovery algorithm
can actually be used in any situation where one searches for differences
between two populations that are expected to be coherent with a known
graph structure. Therefore, our methodological contributions in Sections 3
and 4 are presented in the general context of two-sample tests on graphs.
2. Graph-based dimensionality reduction. As stated in the Introduction,
each of the two main paradigms for testing differential expression of a gene
set have their limitations. Two-step methods generally do not directly test
the existence of a mean shift between two multivariate distributions [Goe-
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Fig. 1. Synthetic example of the joint distribution of the expression measures of two
genes in two patient populations. The color and shape of the plotting symbols indicate the
patient group and the x- and y-axes correspond to the expression measures of the first and
second gene, respectively.
man and Bu¨hlmann (2007)]. The second step, which often treats the genes
as the sampling units, renders the interpretation of p-values problematic
and may lead to a large loss of power or Type I error control when sets of
genes have correlated expression. Multivariate statistics, on the other hand,
allow a direct formulation of and solution to the testing question: the sam-
pling units are vectors of gene expression measures (e.g., corresponding to
patients) and the question is whether two such sets of random vectors are
likely to have arisen from distributions with equal means. Figure 1 illus-
trates another classical advantage of multivariate approaches: genes taken
individually may have extremely small mean shifts between two populations,
although their joint distributions clearly differ between the two populations.
Here, again, this phenomenon typically happens for sets of genes whose
expression measures are correlated, which is not unlikely for pathways or
annotated gene sets.
Unfortunately, with moderate sample sizes, multivariate statistics lose
power quickly in a high dimension. If some type of side information is avail-
able regarding particular properties of the expression shift, a possible ap-
proach to get the best of both worlds would be to: (1) project the vectors
of covariates in a new space of lower dimension that preserves the distribu-
tion shift, that is, the distance between the expression measures of the two
groups, and (2) apply the multivariate statistic in this new space. One could
thus perform the appropriate multivariate test, while avoiding the loss of
power caused by the high-dimensionality of the original covariate space.
A possible source of information about the expression shift is the growing
number of available gene networks. Indeed, while the difference in mean ex-
pression between two groups of patients may not be entirely coherent with
an existing network (e.g., because of noise in the data, errors in the annota-
tion, or inappropriateness of the chosen network for the biological question
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of interest), it is reasonable to expect that this shift will not be entirely
contradictory with the given graph structure. For example, repressed genes
should be more connected to other repressed genes than to overexpressed
genes. Given this assumption, we intend to build a space of lower dimension
than the original gene space, but which preserves most of the distribution
shift between the two populations.
More precisely, consider a network of p genes, represented by a graph
G = (V,E), with |V|= p nodes and edge set E . Let δ ∈ Rp denote the mean
shift, that is, the vector of differences in mean expression measures for these p
genes between the two populations of interest. Suppose we expect the shift δ
to be coherent with the graph G, in the sense that it has low energy EG(δ) for
a particular energy function EG defined on G. Then, we wish to build a space
of lower dimension k≪ p capturing most of the low energy functions. To this
end, we start by finding the function that has the lowest possible energy,
then the function that has lowest possible energy in the orthogonal space of
the first one, up to the kth function with lowest energy in the orthogonal
subspace of the first k− 1 functions. That is, for each i≤ k, we define
ui =
{
argmin
f∈Rp
EG(f)
such that ui ⊥ uj , j < i.
(2.1)
If EG is a positive semi-definite quadratic form EG(δ) = δ⊤QGδ, for some
positive semi-definite matrix QG = UΛU⊤, where U is an orthogonal matrix
and Λ a diagonal matrix with elements λi, i= 1, . . . , p, then the solution to
equation (2.1) is given by the k eigenvectors of QG corresponding to the
smallest k eigenvalues. It is easy to check that these eigenvalues are the
energies of the corresponding functions ui, that is, EG(ui) = λi.
Different choices of QG lead to different notions of coherence of the ex-
pression shift with the network. A classical choice is the graph Laplacian L.
Suppose G is an undirected graph with adjacency matrix A, with aij = 1 if
and only if (i, j) ∈ E and aij = 0 otherwise, and degree matrix D=Diag(A1),
where 1 is a unit column-vector, Diag(x) is the diagonal matrix with diag-
onal x for any vector x, and Dii = di. The Laplacian matrix of G is then
typically defined as L=D−A or Lnorm = I−D−1/2AD−1/2 for the normal-
ized version, leading to energies
∑
i,j∈V(δi − δj)2 and
∑
i,j∈V(
δi√
di
− δj√
dj
)2,
respectively. Note that, in this case, the Laplacian matrix L, energy E and
basis functions ui extend the classical Fourier analysis of functions on Eu-
clidean spaces to functions on graphs, by transferring the notions of Laplace
operator, Dirichlet energy and Fourier basis, respectively [Evans (1998)].
More generally, any positive semi-definite matrix can be chosen. In the
case of gene regulation networks, we do not necessarily expect as strong
a coherence as that corresponding to the Dirichlet energy defined by the
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graph Laplacian, since some of the annotated interactions may not be rel-
evant in the studied context and some antagonist interactions may cancel
each other. For example, if a gene is activated by two others, one who is
underexpressed and the other overexpressed, we may observe no change in
the expression of the gene, but a nonzero Dirichlet energy
∑
i,j∈V(δi − δj)2.
Additionally, for applications like structured gene set differential expression
detection, one may use negative weights for edges that reflect a negative
correlation between two variables, for example, a gene i whose expression
inhibits the expression of another gene j. In this case, a small variation of
the shift on the edge between i and j should correspond to a small |δi + δj |.
This can be achieved in the same formalism by simply considering a signed
version of the adjacency matrix A, that is, aij = 1 if gene i activates gene j
and −1 if it inhibits gene j. A signed version of the graph Laplacian is then
Lsign =D −A, where D =Diag(|A|1) is the degree matrix and |A| denotes
the entry-wise absolute value of A. Note that such a signed Laplacian was
used as a penalty for semi-supervised learning in Goldberg (2007).
In the context of this work, we, moreover, consider directed graphs G =
(V,E), where the edge set E consists of ordered pairs of nodes. The adjacency
matrix A may be asymmetric, with entries aij 6= 0 if and only if (i, j) ∈ E ,
that is, there is an (directed) edge pointing from node vi to node vj . We
then use the following energy function:
EG(δ) =
p∑
i:d−i 6=0
(
δi − 1
d−i
∑
(j,i)∈E
ajiδj
)2
,(2.2)
where d−i
∆
=
∑p
j=1 |aji| is the indegree of node vi, that is, the number of
directed edges pointing from any node to vi. According to this definition, an
expression shift will have low energy if the difference in mean expression of
any given gene between the two populations is similar to the (signed) average
of the differences in mean expression for the genes that either activate or
inhibit it.
It is immediate to check that EG(δ)=δ⊤MGδ, withMG
∆
=(I˜−D−1− A⊤)⊤(I˜−
D−1− A⊤), where D−
∆
= Diag((d−i )i=1,...,p) is the matrix of indegrees, I˜
∆
=
Diag((I(d−i 6= 0))i=1,...,p) is a modification of the identity matrix where di-
agonal elements corresponding to nodes with zero indegree are set to zero,
and the value of the indicator function I is 1 if its argument is true and
zero otherwise. Note that a very similar function was used in the context of
regularized supervised learning by Sandler et al. (2009).
Following our principle to build a lower dimension space, we use the first
few eigenvectors of MG to obtain orthonormal functions with low energy. As
an example, Figure 2 displays the eigenvectors of MG for a simple four-node
8 L. JACOB, P. NEUVIAL AND S. DUDOIT
Fig. 2. Eigenvectors of the signed Laplacian Lsign for the simple undirected four-node
graph of example (2.3). The eigenvectors of MG for this particular network are the same.
The corresponding eigenvalues are 0,1,1, 16
3
for MG and 0,1,1,4 for Lsign. Nodes are
colored according to the value of the eigenvector, where green corresponds to high positive
values, red to high negative values, and black to 0. “T”-shaped edges have negative weights.
graph with
D =


1 0 0 0
0 3 0 0
0 0 1 0
0 0 0 1

 , A=


0 1 0 0
1 0 1 −1
0 1 0 0
0 −1 0 0

 ,(2.3)
where A takes on negative values for negative interactions, such as expres-
sion inhibition. The first eigenvector, corresponding to the smallest energy
(eigenvalue of zero), can be viewed as a “constant” function on the graph,
in the sense that its absolute value is identical for all nodes, but nodes con-
nected by an edge with negative weight take on values of opposite sign. By
contrast, the last eigenvector, corresponding to the highest energy, is such
that nodes connected by positive edges take on values of opposite sign and
nodes connected by negative edges take on values of the same sign. Note
that, for this particular example, the adjacency matrix is symmetric, which
need not always be the case. Here, the signed Laplacian turns out to have
the same eigenvectors as MG , which is not the case generally.
Consider now a slightly different graph, with directed edges, only positive
interactions to avoid confusion, and adjacency matrix
A=


0 1 0 0
0 0 0 0
0 1 0 0
0 1 0 0

 .(2.4)
For this graph, Figure 3 shows that the two notions of energy lead to two
different bases. While the signed Laplacian matrix (by definition based on
a symmetrized version of A for an undirected graph) has only one (constant)
eigenvector of null energy, two of energy 1, and one of 4, MG has three
orthogonal vectors of null energy. Note, however, that the first and last
eigenvectors are still the same across the two bases.
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Fig. 3. Eigenvectors of the signed Laplacian Lsign (top) and of MG (bottom) for the sim-
ple directed four-node graph of example (2.4). The corresponding eigenvalues are 0,1,1,4
and 0,0,0, 4
3
, respectively. Nodes are colored according to the value of the eigenvector,
where green corresponds to high positive values, red to high negative values, and black to 0.
More generally, this illustration suggests that projecting on the first eigen-
vectors of MG will not preserve the same shifts as projecting on the first
eigenvectors of Lsign. It is possible for a shift vector to have low energy (2.2)
but larger signed Dirichlet energy
∑
i,j∈V(δi−aijδj)2, where we recall that aij
is 1 for an edge indicating a positive interaction between i and j and −1 for
an edge indicating a negative interaction. This is, for example, the case of
the second eigenvector of MG on the bottom row of Figure 3. It is therefore
conceivable that such a shift essentially lies in the space spanned by the first
few eigenvectors of MG , but that its projection in the space formed by the
first few eigenvectors of Lsigned is smaller. As a consequence, for a particular
shift using one basis or the other for dimensionality reduction will lead to
more or less gain in power, which means that the choice of basis should be
adapted to the expected type of smoothness of the shift.
While we introduce the idea in the context of gene regulation networks
and testing for differential expression, the same dimensionality reduction
principle applies to any multivariate testing problem for which the variables
have a known structure, as represented by a graph.
As a last remark, we emphasize that our requirement that the shift be
coherent with the network is not too strict in practice. It may sound like
most pairs of nodes must have shifts whose directions are consistent with
the nature of the edge connecting the nodes, but:
• In practice, keeping a few eigenvectors already allows to represent several
types of shifts which are not perfectly coherent with the network, as illus-
trated on Figure 2. The projection only shrinks those shifts which severely
contradict the prior given by the network.
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• In Section 5.2 we illustrate the fact that this type of projection still leads
to gain in power even in case of strong misspecifications in the network,
that is, when a lot of edges are missing or wrong.
• Lopes, Jacob and Wainwright (2011) show that in a high dimension, ran-
dom projection of the data in a lower dimension space yields gains in power
against the regular Hotelling T 2 in the presence of correlation and if the
spectrum of the covariance matrix decays fast enough. This result sug-
gests that there is hope to gain power even in the case where the network
doesn’t bring much information about the shift.
In the remainder of this paper we denote by f˜ = U⊤f the coefficients of
a vector f ∈R|V| after projection on a basis U (typically the eigenvectors of
a QG matrix).
3. Graph-structured two-sample test of means under smooth-shift alter-
natives. For multivariate normal distributions, Hotelling’s T 2-test, a clas-
sical test of location shift, is known to be a uniformly most powerful in-
variant against global-shift alternatives. The test statistic is based on the
squared Mahalanobis norm of the sample mean shift and is given by T 2 =
n1n2
n1+n2
(x¯1 − x¯2)⊤Σˆ−1(x¯1 − x¯2), where ni, x¯i and Σˆ denote, respectively, the
sample sizes, means and pooled covariance matrix, for random samples
drawn from two p-dimensional Gaussian distributions, N (µi,Σ), i = 1,2.
Under the null hypothesis H0 : µ1 = µ2 of equal means, NT
2 follows a (cen-
tral) F -distribution F0(p,n1+n2−p−1), where N = n1+n2−p−1(n1+n2−2)p . In general,
NT 2 follows a noncentral F -distribution F ( n1n2n1+n2∆
2(δ,Σ);p,n1+n2−p−1),
where the noncentrality parameter is a function of the Mahalanobis norm of
the mean shift δ, ∆2(δ,Σ) = δ⊤Σ−1δ, which we refer to as the distribution
shift. In the remainder of this paper, unless otherwise specified, T 2-statistics
are assumed to follow the nominal F -distribution, for example, for critical
value and power calculations.
For any orthonormal basis U and, in particular, for our graph-based basis,
direct calculation shows that T 2=T˜ 2
∆
= n1n2n1+n2 (x¯1−x¯2)⊤U(U⊤ΣˆU)−1U⊤(x¯1−
x¯2), that is, the statistic T
2 in the original space and the statistic T˜ 2 in the
new graph-based space are identical. More generally, for k ≤ p, the statistic
in the original space after filtering out dimensions above k is the same as the
statistic T˜ 2k restricted to the first k coefficients in the new space defined by U :
T˜ 2k
∆
=
n1n2
n1 + n2
(x¯1 − x¯2)⊤U[k](U⊤[k]ΣˆU[k])−1U⊤[k](x¯1 − x¯2)
=
n1n2
n1 + n2
(x¯1 − x¯2)⊤U1kU⊤(U1kU⊤ΣˆU1kU⊤)+U1kU⊤(x¯1 − x¯2),
where A+ denotes the generalized inverse of a matrix A, the p×k matrix U[k]
denotes the restriction of U to its first k columns, and 1k is a p× p diagonal
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matrix, with ith diagonal element equal to one if i≤ k and zero otherwise.
Note that, as retaining the first k dimensions corresponds to a noninvert-
ible transformation, this filtering indeed has an effect on the test statistic,
that is, we have T˜ 2k 6= T˜ 2 in general. As the Mahalanobis norm is invari-
ant to invertible linear transformations, using an invertible filtering (such as
weighting each component according to its corresponding eigenvalue) would
have no impact on the test statistic.
Hotelling’s T 2-test is known to behave poorly in the high dimension;
Lemma 1 stated and proved in the supplemental article Supplement A [Ja-
cob, Neuvial and Dudoit (2011a)] shows that gains in power can be achieved
by filtering. Specifically, let δ˜ = U⊤δ and Σ˜ = U⊤ΣU denote, respectively,
the mean shift and covariance matrix in the new space. Given k ≤ p, let
∆2k(δ,Σ) = δ
⊤
[k](Σ[k])
−1δ[k] denote the distribution shift restricted to the first k
dimensions of δ and Σ, that is, based on only the first k elements of δ,
(δi : i ≤ k), and the first k × k diagonal block of Σ, (σij : i, j ≤ k). Under
the assumption that the distribution shift is smooth, that is, lies mostly in
the first few graph-based coefficients, so that ∆2k(δ˜, Σ˜) is nearly maximal for
a small value of k, Lemma 1 states that performing Hotelling’s test in the
new space restricted to its first k components yields more power than testing
in the entire new space. Equivalently, the test is more powerful in the origi-
nal space after filtering than in the original unfiltered space. The increase in
shift η(α,k, l) required to maintain power when increasing dimension can be
evaluated numerically for any (α,k, l). Note that this result holds because
retaining the first k new components is a noninvertible transformation.
Corollary 1 in the supplemental article Supplement A [Jacob, Neuvial and
Dudoit (2011a)] states that if the distribution shift lies in the first k new
coefficients, then testing in this subspace yields strictly more power than
using additional coefficients. In particular, if there exists k < p such that
δ˜j = 0 ∀j > k (i.e., the mean shift is smooth) and Σ˜ is block-diagonal such
that σ˜ij = 0 ∀i < k, j > k, then gains in power are obtained by testing in the
first k new components. Although nonnecessary, this condition is plausible
when the mean shift lies at the beginning of the spectrum (i.e., has low
energy), as the coefficients which do not contain the shift are not expected
to be correlated with the ones that do contain it.
Note that the result in Lemma 1 is more general, as testing in the first k
new components can increase power even when the distribution shift par-
tially lies in the remaining components, as long as the latter portion is below
a certain threshold. Figure 4 illustrates, under different settings, the increase
in distribution shift necessary to maintain a given power level against the
number of added coefficients.
Under the assumption of block-diagonal covariance, Corollary 2 (in the
supplemental article Supplement A [Jacob, Neuvial and Dudoit (2011a)])
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Fig. 4. Left: Increase in distribution shift required for Hotelling’s T 2-test to maintain
a given power when increasing the number of tested new coefficients: ∆2k+l − ∆
2
k vs. l
such that βα,k+l(∆
2
k+l) = βα,k(∆
2
k). Power βα,k+l(∆
2
k+l) computed under the noncentral
F -distribution F ( n1n2
n1+n2
∆2k+l;k+ l, n1 + n2 − (k+ l)− 1), for n1 = n2 = 100 observations,
k = 5, and α= 10−2. Each line corresponds to the fixed shift ∆2k and power βα,k(∆
2
k) pair
indicated in the legend. Right: Zoom on the first 30 dimensions.
directly relates the energy of the mean shift vector to the gain in power. It
states that if the energy of the mean shift vector δ is small enough, that
is, if the mean shift is coherent enough with the network, then testing in
the first k dimensions of the new basis is more powerful than testing in the
original space. The corresponding upper bound on the mean shift energy can
be quantified for a given generative setting (µ1, µ2,Σ), graph G and level α.
Tighter and looser bounds can be straightforwardly derived using the same
principle for the diagonal and general covariance cases, respectively.
4. Nonhomogeneous subgraph discovery. A systematic approach for dis-
covering nonhomogeneous subgraphs, that is, subgraphs of a large graph that
exhibit a significant shift in means, is to test all of them one-by-one.
This poses a huge combinatorial problem even for moderately large graphs
(p = 50, say), as the number of (connected) subgraphs of size k of a graph
of size p can be exponential in p and k. Exhaustive search is therefore not
feasible in practice, especially for differential expression on gene networks,
where p is typically in the dozens or hundreds of genes. Therefore, it is impor-
tant to rapidly identify sets of subgraphs that all satisfy the null hypothesis
of equal means. To this end, we prove an upper bound on the value of the test
statistic for any subgraph containing a given set of nodes (Lemma 2 in the
supplemental article Supplement A [Jacob, Neuvial and Dudoit (2011a)]).
An exact algorithm is derived from this upper bound in Section 4.1, and
a quicker, approximate algorithm is proposed in Section 4.2.
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Algorithm 1: Nonhomogeneous subgraph discovery algorithm. The sub-
graphBoundary of a subgraph g of G is defined as the set of supergraphs
of g obtained by adding any one node of G which is connected to a node
of g.
Input: G,X1,X2, α, q
Output: selectedSubgraphs
selectedSubgraphs =∅;1
previousSubgraphs = nodes (G);2
prunedSubgraphs =∅;3
foreach s ∈ {1 . . .q− 1} do4
checkedSubgraphs =∅;5
foreach previousSubgraph do6
foreach subgraph ∈ subgraphBoundary(previousSubgraph) do7
if subgraph has been checked or has a pruned subgraph then next;8
if s < q− 1 then9
if upperBound(subgraph,G,X1,X2, q)<T 2α,k then10
add subgraph to prunedSubgraphs;11
else12
add subgraph to currentSubgraphs;13
end14
else15
foreach q-subgraph∈ subgraphBoundary(subgraph) do16
if q-subgraph has been checked or has a pruned subgraph17
then
next18
else19
if T˜ 2k (q-subgraph,X1,X2)> T
2
α,k then20
add q-subgraph to selectedSubgraphs21
end22
add q-subgraph to checkedSubgraphs23
end24
end25
end26
add subgraph to checkedSubgraphs27
end28
end29
set previousSubgraphs to currentSubgraphs30
end31
4.1. Exact algorithm. Given a large graph G with p nodes, we adopt
a branch-and-bound-like approach [Land and Doig (1960)] to test subgraphs
of size q ≤ p at level α, as described in Algorithm 1. We start by checking,
for each node in G, whether the Hotelling T 2-statistic in the first k new
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components of any subgraph of size q containing this node can be guaran-
teed (by virtue of Lemma 2) to be below the level-α critical value T 2α,k, for
example, (1−α)-quantile of F0(k,n1+n2− k− 1) distribution. If this is the
case, the node is pruned, that is, removed from the graph. The algorithm
iteratively enriches a list of pruned subgraphs and a list of candidate sub-
graphs (called prunedSubgraphs and currentSubgraphs in Algorithm 1,
resp.) of increasing number of nodes s= 1, . . . , q − 1. Pruned subgraphs are
those for which one can guarantee that no supergraph of size q can reach
significance level α, and candidate subgraphs are those for which this guar-
antee cannot be given. The key of the algorithm is that at step s, only those
graphs containing a candidate subgraph have to be considered.
This guarantee is obtained by applying Lemma 2 in the supplemental
article Supplement A [Jacob, Neuvial and Dudoit (2011a)], which gives an
upper bound on the value of the test statistic for any subgraph containing
a given set of nodes. For a subgraph g of G of size q ≤ p, Hotelling’s T 2-
statistic in the first k ≤ q new components of g is defined as
T˜ 2k (g) =
n1n2
n1 + n2
(x¯1(g)− x¯2(g))⊤U[k](U⊤[k]Σˆ(g)U[k])−1U⊤[k](x¯1(g)− x¯2(g)),
where U[k] is the q × k restriction of the matrix of q eigenvectors of Qg
to its first k columns [i.e., U[k](g), where we omit g to ease notation] and
x¯i(g), i = 1,2, and Σˆ(g) are, respectively, the empirical means and pooled
covariance matrix restricted to the nodes in g. Lemma 2 states that for any
number k of retained components, and for any subgraph g′ of size q′ of g,
T˜ 2k (g) is upper bounded by the T
2 statistic of the subgraph whose nodes are
in ν(g′, q− q′), that is, the union of the nodes of g′ and the nodes of g whose
shortest path to a node of g′ is less than or equal to r. The set ν(g′, r) is
called the r-neighborhood of g′. As a corollary of Lemma 2, the subgraphs
returned by Algorithm 1 are exactly those who exhibit a significant shift in
means at the prescribed level α.
Note that the bound in Lemma 2 takes into account the fact that the T 2-
statistic is eventually computed in the first few components of a basis which
is not known beforehand: at each step, for each potential subgraph g′ which
would include the subgraph g which we consider for pruning, the T˜ 2k (g
′) that
needs to be bounded above depends on Qg′ .
4.2. Mean-shift approximation. For “small-world” graphs above a cer-
tain level of connectivity and q large enough, ν(g′, q−s), the (q−s)-neighbor-
hood of g′, tends to be large, at least at the beginning of the above exact
algorithm, and the number of tests actually performed may not decrease
much compared to the total number of possible tests. One can, however,
identify much more efficiently the subgraphs whose sample mean shift in
the first k components of the new space has Euclidean norm ‖ˆ˜δ[k](g)‖ =
‖U⊤[k](x¯1(g)− x¯2(g))‖ above a certain threshold. Indeed, it is straightforward
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to see that
‖U⊤[k](x¯1(g)− x¯2(g))‖2
≤ ‖U⊤(x¯1(g)− x¯2(g))‖2
= ‖x¯1(g)− x¯2(g)‖2
≤ ‖x¯1(g′)− x¯2(g′)‖2
+ max
v1,...,vq−s∈ν(g′,q−s)
‖x¯1(v1, . . . , vq−s)− x¯2(v1, . . . , vq−s)‖2.
Using this inequality yields an upper bound on T˜ 2k (g) that can be used as
upperBound at line 10 of Algorithm 1. This defines a procedure that iden-
tifies all subgraphs for which the Euclidean norm of the sample mean shift
exceeds a given threshold: ‖ˆ˜δ[k](g)‖2 > θ. For any α, if this threshold θ is
low enough, all the subgraphs with T˜ 2k (g) > T
2
α,k are included in this set.
Performing the actual T 2-test on these preselected subgraphs then yields
exactly the set of subgraphs that would have been identified using the ex-
act procedure of Section 4.1. More precisely, Lemma 4, in the supplemental
article Supplement A [Jacob, Neuvial and Dudoit (2011a)], states that for
any subgraph which would be detected by Hotelling’s T 2-statistic T˜ 2k (g) but
not by the Euclidean criterion ‖ˆ˜δ[k](g)‖2, the sample covariance matrix in
the restricted new space (after filtering) has an eigenvalue below a certain
threshold. This implies that such false negative subgraphs (from the Eu-
clidean approximation to the exact algorithm) have a small mean shift in
the new space, but in a direction of small variance. In the context of gene
expression, this is related to the well-known issue of the detection of DE
genes by virtue of their small variances. Even though the differences in ex-
pression appear to be significant for these genes, they correspond to small
effects that may not be interesting from a practical point of view (i.e., bio-
logically nonsignificant). Methods for addressing this problem are proposed
in Lo¨nnstedt and Speed (2002). Note that λmin(Σˆ(g))≤ λmin( ˆ˜Σ[k](g)); thus,
the remark on variances holds for both the new and the original spaces.
However, if q is large, we expect λmin(Σˆ(g)) to be very small, while filtering
somehow controls the conditioning of the covariance matrix.
4.3. Multiple hypothesis testing. Testing for homogeneity over the poten-
tially large number of subgraphs investigated as part of the above algorithms
immediately raises the issue of multiple testing. However, because one does
not know in advance the total number of tests and which tests will be per-
formed specifically, standard multiple testing procedures, such as those in
Dudoit and van der Laan (2008), are not immediately applicable.
In an attempt to address the multiplicity issue, we apply a permuta-
tion procedure to control the number of false positive subgraphs under the
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complete null hypothesis of identical distributions in the two populations.
Specifically, one permutes the class/population labels (1 or 2) of the n1+n2
observations and applies the nonhomogeneous subgraph discovery algorithm
to the permuted data to yield a certain number of false positive subgraphs.
Repeating this procedure a sufficiently large number of times produces an es-
timate of the distribution of the number of Type I errors under the complete
null hypothesis of identical distributions.
We evaluate the empirical behavior of the procedures proposed in Sec-
tions 3 and 4, first on synthetic data, then on breast cancer microarray data
analyzed in the context of KEGG pathways.
5. Results on synthetic data. The performance of the graph-structured
test is assessed in cases where the distribution shift ∆2 satisfies the smooth-
ness assumptions described in Section 3. We first generate a connected ran-
dom graph G with p = 20 nodes and 20 edges. Next, we generate 10,000
data sets in the space corresponding to the basis U defined by the eigenvec-
tors of the QG matrix for the graph G; an inverse transformation is applied
to random vectors generated is this new space. Each data set comprises
n1 = n2 = 20 Gaussian random vectors in R
p, with null mean shift δ for
5000 data sets and nonnull mean shift δ for the remaining 5000. For the
latter data sets, the nonzero shift is built in the first k0 = 3 graph-based
coefficients (the shift being zero for the remaining p− k0 coefficients): δ˜i 6= 0
if and only if i≤ k0 and ∆2(δ,Σ) =∆2(δ˜, Σ˜) = δ˜⊤Σ˜−1δ˜ = 1. We consider two
covariance settings. In the first one, the covariance matrix in the new space
is diagonal, with diagonal elements equal to 1√p . In the second, correlation
is introduced between the shifted coefficients only. Specifically, for i, j ≤ k0,
Σ˜ij =
0.5√
p if i 6= j, Σ˜ii = 0.9√p otherwise.
5.1. Fixed known network. Figure 5 displays receiver operator charac-
teristic (ROC) curves for mean shift detection by the standard Hotelling
T 2-test, T 2 in the first k0 graph-based coefficients, T
2 in the first k0 prin-
cipal components (PC), the adaptive Neyman test of Fan and Lin (1998),
and a modified version of this fourth test where the correct value of k0 is
specified. Note that we do not consider sparse learning approaches [Jacob,
Obozinski and Vert (2009), Jenatton, Audibert and Bach (2009), Obozinski,
Jacob and Vert (2011)], but it would be straightforward to design a realistic
setting where such approaches are outperformed by testing, for example, by
adding correlation between some of the functions under H1.
The first important comparison is between the classical Hotelling T 2-
test vs. the T 2-test in the new graph-based space (Figure 5, top row). As
expected from Lemma 1, testing in the restricted space where the shift lies
performs much better than testing in the full space which includes irrelevant
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Fig. 5. Synthetic data: ROC curves for the detection of a smooth shift. Left: Diagonal
covariance structure. Right: Block-diagonal covariance structure. Top: Comparison of tests
based on the standard Hotelling T 2-statistic in the original space, T 2-statistic in the first
k0 graph-based coefficients, and T
2-statistic in the first k0 principal components. Mid-
dle: Comparison with the statistics of Bai and Saranadasa (1996) (BS), Chen and Qin
(2010) (CQ), and Srivastava and Du (2008) (SD). Bottom: Comparison with the Neyman
statistics of Fan and Lin (1998).
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Fig. 6. Synthetic data: Sensitivity to choice of k. Power of the T 2-test in the first k
graph-based coefficients for a graph of 20 nodes, when the actual distribution shift ∆2 = 1
is evenly distributed among the first k0 = 5 graph-based coefficients and with n1 = n2 = 20.
coefficients. The difference can be made arbitrarily large by increasing the
dimension p and keeping the shift unchanged. The graph-structured test re-
tains a large advantage even for moderately smooth shifts, for example, when
k0 = 3 and p = 5. Of course, this corresponds to the optimistic case where
the number of shifted coefficients k0 is known. Figure 6 shows the power of
the test in the new space for various choices of k. Even when missing some
coefficients (k < k0) or adding a few irrelevant ones (k > k0), the power of
the graph-structured test is higher than that of the T 2-test in the full space.
The principal component approach is shown in Figure 5 (top row) because it
was proposed for the application which motivated our work [Ma and Kosorok
(2009)] and because it also illustrates that the improvement in performance
originates not only from dimensionality reduction, but also from the fact
that this reduction is in a direction that does not decrease the shift. We
emphasize that power entirely depends on the nature of the shift and that
a PC-based test would outperform our graph-based test when the shift lies
in the first principal components rather than graph-based coefficients.
The panels in the middle row show that the statistics of Bai and Saranadasa
(1996), Chen and Qin (2010) and Srivastava and Du (2008) are also largely
outperformed by our graph-structured statistic. This observation suggests
that when such a graph-based prior on the shift is available, working in the
new, lower-dimensional space does better at solving the problem of high-
dimensionality than methods based on diagonal approximations of the co-
variance matrix. In addition, as one could expect, the procedures of Bai and
Saranadasa (1996), Chen and Qin (2010) and Srivastava and Du (2008) per-
form very poorly in the presence of correlation. Here again, for a nonsmooth
shift, the comparison would be less favorable to our procedure. We also con-
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sidered the recently-proposed random projection approach of Lopes, Jacob
and Wainwright (2011). Random projection was shown to give more power
than Bai and Saranadasa (1996), Chen and Qin (2010) and Srivastava and
Du (2008) in high-dimensional cases. However, as expected in our simulation
setting where the sample size is twice the number of dimensions, it did not
improve upon the Hotelling T 2-test (ROC curve not shown for the sake of
readability). The method of Lopes, Jacob and Wainwright (2011) is more
appropriate in a higher dimension and when no prior on the shift direction
is available.
Finally, we consider the adaptive Neyman test of Fan and Lin (1998)
(bottom two panels of Figure 5), which takes advantage of smoothness as-
sumptions for time series. This test differs from our graph-structured test,
as Fourier coefficients for stationary time series are known to be asymptot-
ically independent and Gaussian. For graphs, the asymptotics would be in
the number of nodes, which is typically small, and necessary conditions such
as stationarity are more difficult to define and unlikely to hold for data such
as gene expression measures. In the uncorrelated setting, the modified ver-
sion of the Fan and Lin (1998) statistic based on the true number of nonzero
coefficients performs approximately as well as the graph-structured T 2. How-
ever, for correlated data, it loses power and both versions of the Neyman test
can have arbitrarily degraded performance. This, together with the need to
use the bootstrap to calibrate the test, illustrates that direct transposition
of the Fan and Lin (1998) test to the graph context is not optimal.
5.2. Fixed network with errors. We now consider the less idealistic case
where the network used for testing is not exactly the one which was used to
generate the data. More precisely, we follow the same procedure as in the
correlated case of Section 5.1, but remove or add some edges to the network
between the moment where we use it to generate the two samples and the
moment where we use it in our testing procedure. This setting is much closer
to what is likely to happen with real data, as available networks may miss
several gene interactions which are not known yet and may include some
incorrect interactions or some which are irrelevant for the problem under
consideration. It is easy to see that in a worst case scenario, removing or
adding an edge to the network can arbitrarily shrink the T 2k statistic. Take,
for example, two disconnected nodes and assume without loss of generality
that the empirical covariance matrix is the identity matrix and the empirical
mean shifts for the two nodes are 1 and −1. Then, δ⊤δ is 2, but adding
an edge between the two nodes and projecting on the first eigenvector of
the graph Laplacian matrix shrinks the observed shift to 0. A probabilistic
analysis over random perturbations would be out of the scope of this paper,
but the following simulation study is intended to give insight into what
would happen in practice if randomly chosen edges are either wrongly added
or omitted.
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Fig. 7. Synthetic data: ROC curves for the detection of a smooth shift in the presence
of errors in the network. Comparison of tests based on the standard Hotelling T 2-statistic
in the original space and T 2-statistic in the first k graph-based coefficients. Top: After
randomly removing 20 (left) and 40 (right) edges. Bottom: After randomly adding 20 (left)
and 40 (right) edges.
For the sake of clarity, Figure 7 only shows ROC curves for our graph-
structured T 2 with k = 2,3,4, and the standard Hotelling T 2-statistic. The
other competitors [Bai and Saranadasa (1996), Ma and Kosorok (2009),
Chen and Qin (2010), Fan and Lin (1998), Srivastava and Du (2008), Lopes,
Jacob and Wainwright (2011)] considered above all perform similarly to the
Hotelling T 2-statistic. In the case where edges are erroneously removed, we
start with a true network having 60 edges instead of 20 in Section 5. Figure 7
shows that our graph-based approach can still perform much better than
all competing methods, even in cases where the topology of the observed
network is very incomplete (1/3 of the true number of edges) or noised by
a lot of spurious edges. Figure 8 shows examples of networks corrupted by
removing (top row) or adding (bottom row) edges to the original one and
used in this experiment. It is visually clear that the information provided
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Fig. 8. Synthetic data: Examples of corrupted networks used to generate Figure 7. Left
column: original network used to generate the data of Section 5.2 before removing (top
row) and adding (bottom row) edges. Middle column: one instance of removing/adding 20
edges. Right column: one instance of removing/adding 40 edges.
to our procedure is very different from the one, that is, used to generate
the data. Again, this is an encouraging result, as it is well known that the
gene networks available in the literature are missing a lot of interactions and
often include incorrect information.
5.3. Branch-and-bound subgraph discovery. To evaluate the performance
of the subgraph discovery algorithms proposed in Section 4, we generated
a graph of 100 nodes formed by tightly-connected hubs of sizes sampled
from a Poisson distribution with parameter 10 and only weak connections
between these hubs (Figure 9). Such a graph structure is intended to mimic
the typical topology of gene regulation networks. We randomly selected one
subgraph of 5 nodes to be nonhomogeneous, with smooth shift in the first
k0 = 3 coefficients. The mean shift was set to zero on the rest of the graph.
We set the norm of the mean shift to 1 and the covariance matrix to identity,
so that detecting the shifted subgraph is impossible by just looking at the
mean shift on the graph.
We evaluated run-time for full enumeration, the exact branch-and-bound
algorithm based on Lemma 2 (Section 4.1), and the approximate algorithm
based on the Euclidean norm (Section 4.2). We also examined run-time on
data with permuted class labels, as the subgraph discovery procedure is to be
run on such data to evaluate the number of false positives and adjust for mul-
tiple testing. Averaging over 20 runs, the full enumeration procedure took
732± 9 seconds per run and the exact branch-and-bound 627± 59 seconds
on the nonpermuted data and 578 ± 100 seconds on permuted data. Over
100 runs, the approximation at θ = 0.5 (λmin = 0.52) took 204± 86 seconds
(129± 91 on permuted data) and the approximation at θ = 1 (λmin = 1.04)
took 183± 106 seconds (40± 60 on permuted data). The latter approxima-
tion missed the nonhomogeneous subgraph in 5% of the runs.
While neither the exact nor the approximate bounds are efficient enough
to allow systematic testing on huge graphs for which the full enumeration
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Fig. 9. Synthetic data: Random graph used in the evaluation of the pruning procedure.
approach would be impossible, they allow a significant gain in speed, espe-
cially for permuted data, and will thus prove to be very useful for multiple
testing adjustment.
6. Results on cancer gene expression data. We also validated our meth-
ods using the following two microarray expression data sets: a breast cancer
data set [Loi et al. (2008)] and a bladder cancer data set [Stransky et al.
(2006)].
Breast cancer data set. The first data set by Loi et al. (2008) comprises
the expression measures of 15,737 genes for 255 ER+ breast cancer patients
treated with tamoxifen. Breast tumors are generally classified into three
main categories [Perou et al. (2000)]: luminal epithelial/ER+, HER2+, and
triple negative. ER+ tumors typically express estrogen receptors at a high
level and often rely on estrogen for their growth. Tamoxifen is an antagonist
of estrogen receptors and therefore prevents its activation by endogenous
estrogen. Some ER+ tumors, however, keep growing after being treated
with tamoxifen. An important goal is to detect structured groups of genes
which are differentially expressed between resistant and sensitive patients,
as detecting such groups could help understand resistance mechanisms and
eventually improve ER+ breast tumor treatment. Using distant metastasis-
free survival as a primary endpoint, 68 patients from this data set are labeled
as resistant to tamoxifen and 187 are labeled as sensitive to tamoxifen.
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Bladder cancer data set. The second data set by Stransky et al. (2006)
consists of the expression measures of 8323 genes for 57 urothelial tumors.
Urothelial tumors are known to be arising and evolving through two dis-
tinct pathways, one typically leading to low-grade noninvasive tumors (Ta
tumors), the other involving more aggressive tumors [Bakkar et al. (2003),
Knowles (2006)]. These two subtypes, however, are not distinguishable from
simple markers such as estrogen receptor or HER2 status for breast tumors.
Mutation of the FGFR3 gene is sometimes used as a proxy, as about 70%
of the noninvasive tumors carry it. As this information was unfortunately
not available for this data set, we used the second best proxy which is tu-
mor stage. We defined two groups: 25 tumors either at the Ta or T1 stages
(TaT1 group) and 32 tumors at the T2, T3 or T4 stages (T2+ group).
The muscle invasive T2+ tumors are aggressive and present a high risk of
metastasis, while the Ta tumors have high recurrence level but low chance of
progression into muscle invasive tumors. Identifying pathways which differ
in expression between the two subtypes could help understand the disease
better and improve its treatment.
6.1. KEGG networks.
Breast cancer data set. Starting with the breast cancer data set, we tested
individually 351 connected components from 100 KEGG pathways corre-
sponding to known gene regulation networks listed in the supplemental ar-
ticle Supplement B [Jacob, Neuvial and Dudoit (2011b)], using the classical
Hotelling T 2-test and the T 2-test in the new graph-based space retaining
only the first 20% coefficients (k = 0.2p). This value was the one chosen
in Rapaport et al. (2007) on the same networks, accordingly with an ar-
gument based on loss minimization, not on hypothesis testing. The anal-
ysis of Lopes, Jacob and Wainwright (2011) suggests that the projection
method (on random subspaces in their case) is quite robust to the choice
of k. More refined heuristics could be based on eigengaps, that is, on the dis-
tances between successive eigenvalues. Indeed, matrix perturbation results
suggest that eigenspaces can vary a lot even under small perturbations of
the network if the largest discarded eigenvalue is close to the smallest kept
eigenvalue [Davis and Kahan (1969), Stewart and Sun (1990), Ipsen (2010)].
Values of k such that λk − λk+1 is as large as possible could therefore be
generally preferable.
The networks had 36 nodes in average, with a median of 23. For each
of the 351 graphs, (unadjusted) p-values were computed under the nominal
F -distributions F0(p,n1+n2−p−1) and F0(k,n1+n2−k−1), respectively.
The Benjamini and Hochberg (1995) procedure was then applied to control
the false discovery rate (FDR) at level 0.05.
Since there is no gold standard regarding which pathways are actually
involved in endocrine resistance, practical validation of the entire set of
detected pathways requires advanced biological expertise and further exper-
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Fig. 10. Breast cancer data set: KEGG prostate cancer pathway. Scaled difference in
sample mean expression measures between tamoxifen-resistant and sensitive patients, for
genes in one component of the KEGG prostate cancer pathway. Nodes are colored according
to the value of the difference in means, with green corresponding to high positive values,
red to high negative values, and black to 0. Red arrows denote activation, blue arrows
inhibition.
iments and is the subject of ongoing collaborations. Nonetheless, inspection
of our list reveals several pathways which would not have been detected
(or would have been further down in the list) without accounting for the
network structure and which have recently been shown to be central in ta-
moxifen resistance. Many of these pathways involve the Ras/Raf-1/MAPK
cascade [McGlynn et al. (2009)], like one of the connected components of the
prostate cancer pathway shown in Figure 10 and one connected component
of the GnRH pathway shown in Figure 11. The former also involves the
overexpressed FGFR1, whose amplification was very recently shown to be
implicated in endocrine therapy resistance by Turner et al. (2010). The lat-
ter pathway involves overexpressed SRC, which is also a well-studied target
when trying to prevent tamoxifen resistance [Herynk et al. (2006)]. Both
pathways have a much smaller p-value when accounting for their graph
structure than when testing in the original gene space: 10−4 vs. 0.02 for
the prostate cancer pathway and 10−3 vs. 0.11 for the GnRH signaling
pathway. This is because the differences in expression of individual genes
are insufficient to be significant in 36 and 19 dimensions, respectively, while
GRAPH-STRUCTURED TESTS FOR DIFFERENTIAL EXPRESSION 25
Fig. 11. Breast cancer data set: KEGG GnRH signaling pathway. Scaled difference in
sample mean expression measures between tamoxifen-resistant and sensitive patients, for
genes in one component of the KEGG GnRH signaling pathway. Nodes are colored ac-
cording to the value of the difference in means, with green corresponding to high positive
values, red to high negative values, and black to 0. Red arrows denote activation, blue
arrows inhibition.
the expression shift projected in the first 8 and 4 graph-based directions,
respectively, is significant. Note that the corresponding p-values for the hy-
pergeometric enrichment test are 0.15 and 0.31. The complete gene lists of
the two components are reported in Tables 3 and 4, respectively, in the sup-
plemental article Supplement C [Jacob, Neuvial and Dudoit (2011c)]. Using
a system-based approach like our proposed graph-based test therefore allows
us to recover several known results (which may not have been obvious from
the same data when looking at each gene individually) and may give insight
regarding other resistance mechanisms by highlighting connections between
these results.
Another example of a network selected only when accounting for graph
structure is Leukocyte transendothelial migration, shown in Figure 12. To
the best of our knowledge, this pathway is not specifically known to be in-
volved in tamoxifen resistance. However, its role in resistance is plausible,
as leukocyte infiltration was recently found to be involved in breast tumor
invasion [Man (2010)]; more generally, the immune system and inflamma-
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Fig. 12. Breast cancer data set: KEGG leukocyte transendothelial migration pathway.
Scaled difference in sample mean expression measures between tamoxifen-resistant and
sensitive patients, for genes in one component of the KEGG leukocyte transendothelial
migration pathway. Nodes are colored according to the value of the difference in means,
with green corresponding to high positive values, red to high negative values, and black to 0.
Red arrows denote activation, blue arrows inhibition.
tory response are closely related to the evolution of cancer. Here again, the
p-value of the hypergeometric test is extremely high (0.31). The entire list
of genes in this component is reported in Table 5 in the supplemental arti-
cle Supplement C [Jacob, Neuvial and Dudoit (2011c)].
Bladder cancer data set. Testing the same KEGG networks on the blad-
der cancer data set, we immediately notice that several gene sets which are
well known to be specific of one of the two bladder cancer progression path-
ways have much lower p-values under our graph-based approach than using
the Hotelling T 2-statistic. This is the case, in particular, for the p53 signal-
GRAPH-STRUCTURED TESTS FOR DIFFERENTIAL EXPRESSION 27
Fig. 13. Bladder cancer data set: KEGG p53 signaling pathway. Scaled difference in
sample mean expression measures between T2+ and TaT1 tumors, for genes in one com-
ponent of the KEGG p53 signaling pathway. Nodes are colored according to the value of the
difference in means, with green corresponding to high positive values, red to high negative
values, and black to 0. Red arrows denote activation, blue arrows inhibition.
ing pathway [Spruck et al. (1994), Sanchez-Carbayo et al. (2006)], which is
displayed in Figure 13 and for which the graph-based procedure outputs a p-
value of 8.5×10−6 vs. 0.3 for the classical T 2-statistic. The TP53 gene itself
is overexpressed in invasive (T2+) tumors. van Rhijn et al. (2004) suggested
that FGFR3 and TP53 mutations characterize the two growth pathways and
are mutually exclusive. A more recent study [Herna´ndez et al. (2005)] contra-
dicts the exclusion, but the observed underexpression of TP53 in the invasive
group could be coherent with its typical mutation in invasive tumors. Genes
coding for cyclins, such as CCNB1, CCNB2 and CDC2, are overexpressed.
Cyclins are positively involved in cell proliferation, which is coherent with
their overexpression in invasive tumors, as it was already observed for other
genes of the cyclin family [Levidou et al. (2010)]. IGF1 is also overexpressed
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Fig. 14. Bladder cancer data set: KEGG ErbB signaling pathway. Scaled difference in
sample mean expression measures between T2+ and TaT1 tumors, for genes in one com-
ponent of the KEGG ErbB signaling pathway. Nodes are colored according to the value
of the difference in means, with green corresponding to high positive values, red to high
negative values, and black to 0. Red arrows denote activation, blue arrows inhibition.
in T2+ tumors, known to induce cell proliferation [Dunn et al. (1997)] and
was selected as a prognosis predictor for bladder cancer in Mitra et al. (2009).
We also observe a much lower p-value using our procedure than using the
classical T 2-statistic (2.3× 10−5 vs. 0.066) for the ErbB signaling pathway,
shown in Figure 14 and known to behave differently in the two bladder cancer
growth pathways [Mellon et al. (1996)]. In particular, the network involves
the PIK3, RAS and MAPK genes, which are known to be oncogenes specific
to one of the growth pathways [Eswarakumar, Lax and Schlessinger (2005)].
Finally, changes in the TGF-β signaling pathway are also known to be
related to the aggressiveness of bladder cancers [Hung et al. (2008)]. The
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Fig. 15. Bladder cancer data set: KEGG TGF-β signaling pathway. Scaled difference
in sample mean expression measures between T2+ and TaT1 tumors, for genes in one
component of the KEGG TGF-β signaling pathway. Nodes are colored according to the
value of the difference in means, with green corresponding to high positive values, red to
high negative values, and black to 0. Red arrows denote activation, blue arrows inhibition.
network is shown in Figure 15 and here again our procedure results in a much
lower p-value than the Hotelling test (2.6× 10−6 vs. 0.049).
Unsurprisingly, these three networks have a relatively large size with re-
spect to the low sample size of this data set and several of their genes show
only very moderate differential expression when tested individually.
6.2. NCI networks. We also tested 75 connected components coming
from gene networks of the NCI Pathway IntegrationDatabase.2 The NCI net-
works considered are listed in the supplemental article Supplement B [Jacob,
Neuvial and Dudoit (2011b)]. Unlike KEGG pathways for which the Biocon-
ductor R package KEGGgraph had already been developed, NCI pathways
were not readily available as R objects. We therefore developed NCIgraph
2http://pid.nci.nih.gov.
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[Jacob (2011)], a Bioconductor R package which converts pathways available
in BioPAX format to R objects. In addition, instead of importing a gene net-
work as is into R, we provide an option to convert as well as possible the
original network, whose nodes can represent proteins, protein complexes or
concepts like transport or biochemical reactions, into one whose nodes cor-
respond to genes and whose edges represent direct or indirect interactions
at the expression level. For instance, if protein A is known to activate pro-
tein B, which is a transcription factor for gene C, a relevant network in terms
of gene expression should be A and B pointing to C, whereas the BioPAX
network will most likely be represented as A pointing to B pointing to C.
As discussed in Section 5.2, our method is robust to irrelevant edges in the
graph. Such a transformation is nonetheless important, since the method
essentially uses biological networks as a prior on the covariance structure
of gene expression. After this transformation, however, most networks have
much simpler topologies, typically with all genes pointing to one or a few
targets. As a result, Laplacian eigenvalues often have high multiplicities,
which makes the effect of filtering less drastic.3 In addition, the networks we
consider here have much smaller size than the KEGG networks on average
(8.9 vs. 36 for means, 7.5 vs. 23 for medians), which also explain the milder
difference between results before and after dimensionality reduction.
For the breast cancer data, the 75 connected components we consider are
those which have a nonempty intersection with the genes in this microarray
data set. As for the KEGG networks, we compare the classical Hotelling
T 2-test and the T 2-test in the new graph-based space retaining only the
first 20% coefficients (k = 0.2p).
As an example, NFkB activation by Nontypeable Hemophilus influenzae
shown in Figure 16 includes 21 genes from the breast cancer data set, but
keeping the first 20% of the eigenvalues amounts to keeping 16 dimensions
because of multiplicities. As a consequence, the p-value obtained after filter-
ing is only slightly lower than that before filtering. Here again, the original
context of study for this pathway has nothing to do with breast cancer: the
purpose was to uncover the inflammation and mucin overproduction mech-
anism caused by a particular bacteria. Nevertheless, this network contains
several genes which are either known actors of endocrine resistance or whose
activity can be directly linked to the resistance phenomenon. Moreover, as
one may expect, most of the observed gene-wise differential expression is co-
herent with the annotated interactions. On the lower part of the figure, IL1B
is shown to be overexpressed in sensitive patients. Consistent with this fact,
its negative regulator p38 (MAPK11 and MAPK14) is downregulated in sen-
sitive patients and its positive regulator CREBBP is upregulated. Note that
DUSP1 was incorrectly annotated as a negative regulator in the automatic
3If the eigenvalue 0 has a very high multiplicity, for example, then even the most
extreme filtering still retains a large number of dimensions.
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Fig. 16. Breast cancer data set: NCI Nfkb activation by nontypeable hemophilus influen-
zae pathway. Scaled difference in sample mean expression measures between tamoxifen-re-
sistant and sensitive patients, for genes in one component of the NCI imported BioCarta
Nfkb activation by nontypeable hemophilus influenzae pathway. Nodes are colored according
to the value of the difference in means, with green corresponding to high positive values,
red to high negative values, and black to 0. Red arrows denote activation, blue arrows
inhibition.
network conversion process of NCIgraph but is actually a positive regulator,
as it is involved in the inactivation of p38. NR3C1 is involved in the transcrip-
tion of DUSP1 and is also upregulated in sensitive patients. A few inconsis-
tencies can be observed, like MAP2K3 and MAP2K6 which are negative reg-
ulators of IL1B, yet are overexpressed in sensitive patients. Recall, however,
that the criterion we use for coherence is based on the difference between
the expression of each gene and the (interaction-sign corrected) average ex-
pression of its regulators. The second main output of the pathway, MUC2, is
downregulated in sensitive patients, which makes sense both in terms of the
expression of its negative regulator TGFBR2, which is upregulated, and the
already observed fact [Srinivasan et al. (2007)] that the estrogen receptor
upregulates MUC2 and that tamoxifen could block its expression.
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The role of MUC2 in resistance to tamoxifen treatment of ductal carci-
noma does not seem to be clearly established. Overexpression of MUC2 is
sometimes found to be mildly correlated with good prognosis [Walsh et al.
(1993), Rakha et al. (2005)], but this may be caused by its correlation with
ER+ status. Its overexpression in resistant patients observed in this data
set may well be noncausal, but would deserve further investigation. As for
TGFBR2, inactivating mutations of the gene have been reported to be asso-
ciated with recurrence and tamoxifen resistance [Lu¨cke et al. (2001)], which
is coherent with underexpression in resistant patients. Regarding IL1B, the
main output of the pathway, its overexpression has been shown to be related
to inhibition of cancer growth through apoptosis [Roy, Sarkar and Felty
(2006)]. DUSP1 is a known negative regulator of cell proliferation and over-
expression of p38 is known to be related to tamoxifen resistance [Gutierrez
et al. (2005)]. Interestingly, NR3C1 activity has also been described by Wu
et al. (2005) as being related to breast cancer cell survival through its induc-
tion of MAPK1 expression, which illustrates the interest of studying differen-
tial expression patterns at a system level rather than at the single-gene level.
It is also important to note that at least two interpretations can be given
for the fact that sensitive patients have several gene expression patterns
corresponding to known factors of good prognosis. Some of these patterns
may be caused by the treatment, in which case understanding how tamoxifen
affects these genes in some patients and not in others may be a proxy to
understanding resistance mechanisms. Some of the patterns though may also
have been caused by phenotypic traits of the sensitive patients, leading to
better prognosis but without any link to the treatment.
Another small but relevant example is the sonic hedgehog receptor ptc1
regulates cell cycle pathway shown in Figure 17, which is entirely overex-
pressed in resistant patients, yielding a 10-fold change between the p-value
with and without dimensionality reduction. The genes in this pathway are
known to be related to tamoxifen resistance: CCNB1 is related to prolif-
eration and is part of several existing tamoxifen-resistance signatures [Paik
et al. (2004)] and inhibition of CDC2 was already proposed as an alternative
treatment for endocrine resistant tumors [Johnson et al. (2010)].
6.3. Branch-and-bound subgraph discovery. We ran our branch-and-bound
nonhomogeneous subgraph discovery procedure on the cell cycle pathway,
whose largest connected component, after restriction to edges of known sign
(inhibition or activation), has 86 nodes and 442 edges. Specifically, we sought
to detect differentially expressed subgraphs of size q = 5, after preselecting
those for which the squared Euclidean norm of the empirical shift exceeds
θ = 0.1; for a test in the first k = 3 components at level α= 10−4, this corre-
sponds to λmin < 0.23 and to an expected removal of 95% of the subgraphs
under the approximation that the squared Euclidean norm of the subgraphs
follows a χ25-distribution.
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Fig. 17. Breast cancer data set: NCI sonic hedgehog receptor ptc1 regulates cell cycle
pathway. Scaled difference in sample mean expression measures between tamoxifen-resis-
tant and sensitive patients, for genes in one component of the NCI imported BioCarta
sonic hedgehog receptor ptc1 regulates cell cycle pathway. Nodes are colored according to
the value of the difference in means, with green corresponding to high positive values, red to
high negative values, and black to 0. Red arrows denote activation, blue arrows inhibition.
For α= 10−4, out of 100 runs on permuted data, only 9 rejected the null
hypothesis for at least one subgraph. More precisely, 4 of these 9 runs de-
tected 1 subgraph and the others detected 3, 6, 6, 21 and 26 subgraphs. In
contrast, 41 overlapping subgraphs (Figure 18) were detected on the orig-
inal data, corresponding to a connected subnetwork of 25 genes. Some of
the genes belonging to these networks exhibit large individual differential
expression, namely, TP53 whose mutation has been long known to be in-
volved in tamoxifen resistance [Andersson et al. (2005), Fernandez-Cuesta
et al. (2010)]. Accordingly, its negative regulator MDM2 is overexpressed
and its positive regulator CREBBP is underexpressed. E2F1, whose ex-
pression level was recently shown to be involved in tamoxifen resistance
[Louie et al. (2010)], is also part of the identified network, as well as CCND1
[Barnes (1997), Musgrove and Sutherland (2009)]. Some other genes in the
network have quite low t-statistics and would not have been detected indi-
vidually. This is the case of CCNE1 and CDK2, which were also described
in Louie et al. (2010) as part of the same mechanism as E2F1. Similarly,
CDKN1A was recently found to be involved in anti-estrogen treatment re-
sistance [Musgrove and Sutherland (2009)] and in ovarian cancer, which is
also a hormone-dependent cancer [Cunningham et al. (2009)]. Interestingly,
RBX1, a gene coding for a RING-domain E3 ligase known to be involved in
degradation of estrogen receptor α (ERα) [Ohtake et al. (2007)], appears to
be overexpressed in resistant patients. This fact may suggest that some of
the resistant ER+ patients had fewer receptors and, as a result, their tumors
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Fig. 18. Breast cancer data set: Subgraph discovery. Difference in sample mean expres-
sion measures between tamoxifen-resistant and sensitive patients, for genes in the two
overlapping subgraphs detected at α = 10−4. Nodes are colored according to the value of
the difference in means, with green corresponding to high positive values, red to high neg-
ative values, and black to 0. Red arrows denote activation, blue arrows inhibition.
were relying less on estrogen for their growth, hence, the limited effect of a se-
lective estrogen receptor modulator (SERM) like tamoxifen. The networks
also contain CDK4, whose inhibition was described in Sutherland and Mus-
grove (2009) as acting synergistically with tamoxifen or trastuzumab. More
generally, a large part of the network displayed in Figure 2A of Musgrove
and Sutherland (2009) is included in our network, along with other known
actors of tamoxifen resistance. Admittedly, selecting an important regula-
tor like TP53 is not a surprising result, but our system-based approach to
pathway discovery directly identifies an important set of interacting genes
and may therefore prove to be more efficient than iterative individual iden-
tification of single actors.
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7. Software implementation. The graph-structured test of Section 3 is
implemented in the R software package DEGraph, released through the Bio-
conductor Project (release 2.7). Instructions for download and installation
are available at http://www.bioconductor.org. Note that implementa-
tions of the branch-and-bound algorithms are not yet included in this pack-
age, but are available upon request.
As mentioned in Section 6.2, we also developed NCIgraph [Jacob (2011)],
a Bioconductor R package which converts pathways available in BioPAX
format to R objects with various preprocessing options.
8. Discussion. We developed a graph-structured two-sample test of means,
for problems in which the distribution shift is assumed to be smooth on
a given graph. We proved quantitative results on power gains for such
smooth-shift alternatives and devised branch-and-bound algorithms to sys-
tematically apply our test to all the subgraphs of a large graph, without
enumerating and testing these subgraphs one-by-one. The first algorithm
is exact and reduces the number of explicitly tested subgraphs. The sec-
ond one is approximate, with no false positives and a quantitative result
on the type of false negatives (with respect to the exact algorithm). The
nonhomogeneous subgraph discovery method involves performing a large
number of tests, with highly-dependent test statistics. However, as the ac-
tual number of tested hypotheses is unknown, standard multiple testing
procedures are not directly applicable. Instead, we use a permutation proce-
dure to estimate the distribution of the number of false positive subgraphs.
Such resampling procedures (bootstrap or permutation) are feasible due to
the manageable run-time of the pruning algorithms of Section 4. Results on
synthetic data illustrate the good power properties of our graph-structured
test under smooth-shift alternatives, as well as the good performance of our
branch-and-bound-like algorithms for subgraph discovery. Very promising
results are also obtained on the gene expression data sets of Loi et al. (2008)
and Stransky et al. (2006).
Future work should investigate the use of other bases, such as graph-
wavelets [Hammond, Vandergheynst and Gribonval (2009)], which would
allow the detection of shifts with spatially-located nonsmoothness, for ex-
ample, to take into account errors in existing networks. As for the cutoff
selection, more systematic procedures should be considered, for example,
the two-step method proposed in Das Gupta and Perlman (1974), adaptive
approaches as in Fan and Lin (1998) or heuristics based on the eigengap as
mentioned in Section 6. The pruning algorithm would naturally benefit from
sharper bounds. Such bounds could be obtained by controlling the condition
number of all covariance matrices, using, for example, regularized statistics
which still have known nonasymptotic distributions, such as those of Tai and
Speed (2009). Concerning multiple testing, procedures should be devised to
exploit the dependence structure between the tested subgraphs and to deal
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with the unknown number of tests. The proposed approach could also be en-
riched to take into account different types of data, for example, copy number
for the detection of DE gene pathways. More subtle notions of smoothness,
for example, “and” (resp., “or”) logical relations [Vaske et al. (2010)], could
also be included to represent regulation mechanisms where the simultaneous
presence of two transcription factors (resp., the presence of one or the other)
is necessary to activate the transcription of another gene. Other applications
of two-sample tests with smooth-shift on a graph include fMRI and eQTL
association studies. For fMRI data, the goal would be to detect whether the
brain activity changes between two conditions, using the prior information
that parts of the brain which are close up to brain convolutions or known
connection patterns should exhibit the same kind of change. One could also
want to identify specific areas of the brain whose activity changes between
two conditions. In eQTL studies, people are often interested in finding genes
whose expression is influenced by single-nucleotide polymorphisms (SNPs),
resulting in a large number of individual tests which often need to be ag-
gregated a posteriori at the pathway level. Our method could be used to
identify pathways whose expression is associated with particular SNPs.
Finally, it would be of interest to compare our testing approach with
structured sparse learning (which we briefly described in Section 1) for the
purpose of identifying expression signatures that are predictive of drug re-
sistance. Methods should be compared in terms of prediction accuracy and
stability of the selected genes across different data sets, a central and diffi-
cult problem in the design of such signatures [Ein-Dor et al. (2005), He and
Yu (2010), Haury, Jacob and Vert (2010), Haury, Gestraud and Vert (2011)].
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SUPPLEMENTARY MATERIAL
Supplement A: Technical results and proofs
(DOI: 10.1214/11-AOAS528SUPPA; .pdf). This section contains our techni-
cal results (Lemma and Corollaries) on gain in power along with their proofs.
It also contains the upper bound used in the branch and bound algorithm
with its proof. Finally, it contains the lemma characterizing the subgraphs
that would be missed by the approximated subgraph discovery algorithm
presented in Section 4.2 along with its proof.
Supplement B: Pathways considered in the experiments
(DOI: 10.1214/11-AOAS528SUPPB; .pdf). This section lists the names of
the pathways considered in the experiments.
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Supplement C: Gene lists (DOI: 10.1214/11-AOAS528SUPPC; .pdf). This
section lists the genes belonging to each of the pathways studied in detail in
the experiments along with their t-statistic and corresponding p-value.
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